Diagnostic Digest

Here's what users of BIOFIRE's SARS-CoV-2 syndromic testing solutions should know in response to the WHO's updated testing guidelines.

Pneumonia patients are frequently overtreated with antibiotics due to the difficulty to quickly identify cause. PCR technology helps alleviate this issue.

Viruses have co-existed with humans well before our our earliest evolutionary origins. Learn all about viruses, how they operate, and how they are diagnosed.

November 12th is World Pneumonia day, raising awareness of the infectious disease that claimed 2.5 million lives in 2020, and how to protect against it.

Respiratory Syncytial Virus (RSV) is one of several respiratory pathogens that are active during what’s known as flu season. Learn more.

Increased pathogen detection, reduced hospital length of stay, reduced antibiotic therapies—the BioFire System offers numerous cost saving benefits.

With respiratory pathogens like influenza, RSV, & COVID-19 circulating this winter season, check out these seven ways to protect yourself and family.

What we don't know about COVID-19 still outweighs what we do know, however, COVID-19 isn't the first coronavirus to infect humans. Learn more about coronaviruses.

Epidemiologists work every day to confront a variety of health and safety threats, from influenza to Salmonella infection outbreaks.

Learn the facts about sepsis. 

Dr. Mullis’s groundbreaking invention of polymerase chain reaction (PCR) laid the foundation for BIOFIRE's syndromic testing.

Systematic review and meta-analysis on the impact of molecular rapid diagnostic tests and the role syndromic panels can play in antimicrobial stewardship.